GAMMA Investing LLC raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report) by 38.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,725 shares of the company’s stock after buying an additional 476 shares during the quarter. GAMMA Investing LLC’s holdings in Ryan Specialty were worth $111,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of RYAN. Headlands Technologies LLC acquired a new stake in shares of Ryan Specialty in the 2nd quarter valued at $224,000. Qsemble Capital Management LP acquired a new stake in shares of Ryan Specialty in the 2nd quarter valued at $649,000. Executive Wealth Management LLC acquired a new stake in shares of Ryan Specialty in the 2nd quarter valued at $247,000. Federated Hermes Inc. boosted its stake in shares of Ryan Specialty by 22.4% in the 2nd quarter. Federated Hermes Inc. now owns 552,742 shares of the company’s stock valued at $32,009,000 after purchasing an additional 101,022 shares in the last quarter. Finally, Quantbot Technologies LP boosted its stake in shares of Ryan Specialty by 183.1% in the 2nd quarter. Quantbot Technologies LP now owns 79,686 shares of the company’s stock valued at $4,615,000 after purchasing an additional 51,537 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.
Insider Activity
In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the stock in a transaction that occurred on Wednesday, December 18th. The stock was sold at an average price of $65.17, for a total transaction of $2,280,950.00. Following the completion of the sale, the director now directly owns 50,400 shares of the company’s stock, valued at approximately $3,284,568. This represents a 40.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director David P. Bolger sold 7,055 shares of the stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 126,936 shares of company stock valued at $8,536,282 in the last ninety days. 11.10% of the stock is owned by insiders.
Ryan Specialty Stock Performance
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. During the same period in the prior year, the company posted $0.32 EPS. The company’s revenue was up 20.5% compared to the same quarter last year. Equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.
Ryan Specialty Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.
Wall Street Analyst Weigh In
RYAN has been the topic of several recent analyst reports. Wells Fargo & Company boosted their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. The Goldman Sachs Group upped their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Morgan Stanley began coverage on shares of Ryan Specialty in a research report on Thursday, December 5th. They set an “overweight” rating and a $90.00 price target on the stock. Bank of America upped their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Finally, Barclays upped their price target on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research report on Thursday, November 21st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $75.00.
Get Our Latest Analysis on Ryan Specialty
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
- Five stocks we like better than Ryan Specialty
- 3 Stocks to Consider Buying in October
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings, Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.